Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective

Updated 05/14/2024

Status Withdrawn

Clinical Trial Summary

An open-label,prospective, randomized pilot study to evaluate the efficacy, safety and tolerability of paeoniflorin, for the treatment of autoimmune hepatitis (AIH) with mild necroinflammatory activity on liver biopsy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02878863
Study type	Interventional
Source	West China Hospital
Contact
Status	Withdrawn
Phase	Phase 3
Start date	August 2016
Completion date	July 2017

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT02994537` - Study of the Clinical Features of Autoimmune Hepatitis
	Recruiting	`NCT04617561` - Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II	Phase 4
	Recruiting	`NCT04376528` - Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy	Phase 4
	Not yet recruiting	`NCT05473403` - Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis	N/A
	Terminated	`NCT00286663` - Autoimmune Hepatitis Study	Phase 1
	Withdrawn	`NCT03593460` - Phase II AutoImmune Hepatitis	Phase 2
	Completed	`NCT03941184` - Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
	Completed	`NCT01980745` - CHLOROQUINE FOR MAINTENANCE REMISSION OF AUTOIMMUNE HEPATITIS	Phase 4
	Recruiting	`NCT03146884` - Swiss Autoimmune Hepatitis Cohort Study
	Recruiting	`NCT02997878` - Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH	Phase 1/Phase 2
	Recruiting	`NCT02936596` - Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome	N/A
	Recruiting	`NCT02874586` - Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune Hepatitis	N/A